IGI: The Sparkly Certification Machine That
₹532 Cr PAT. 60% EBITDA Margins. Lab-Grown Diamonds Everywhere. What Could Go Wrong?
₹1,229 crore revenue on 12.81 million reports. Lab-grown diamonds grew 22%, natural diamonds hit +20%. Acquired an American lab (AGL) for $13.2 million. Then just casually declared a ₹2.50 interim dividend. Wild times in the gemology business, apparently.
The Bling Referee Everyone Trusts
- 52-Week High / Low₹442 / ₹287
- CY25 Revenue₹1,229 Cr
- CY25 PAT₹532 Cr
- Full-Year EPS (CY25)₹12.30
- Q4 EPS (Dec 2025)₹3.11
- Book Value₹32.6
- Price to Book9.81x
- Dividend Yield0.77%
- Debt / Equity0.10x
- Interest Coverage75.8x
Welcome to the Certification Cartel Nobody Wanted to Admit Existed
So here’s the most boring and profitable business model ever invented: someone cuts a diamond. You look at it. You write down what you see. You charge them ₹800 to ₹1,200 per report. And repeat 12.81 million times a year.
International Gemmological Institute (IGI) is the world’s largest independent diamond and gemstone certification provider. It’s the referee in the bling game — neutral, trusted, and absolutely boring. It has 31 labs spread across 10 countries, 18 schools of gemology, and over 316 gemologists dissecting rocks all day long.
The business is stupidly simple: natural diamonds need certification. Lab-grown diamonds (a newer, cheaper alternative) need certification even more because buyers panic about “glass.” Studded jewellery needs certification. Coloured stones need certification. And every single certificate generates fees that fall straight to the bottom line at a 60% EBITDA margin.
IPO’d in December 2024 at ₹4,225 crore valuation. The stock is now at ₹13,852 crore. Acquired an American lab (AGL) for $13.2 million in February 2026. Declared a ₹2.50 interim dividend. Moved to April-March reporting. Everything is execution, scale, and watching the diamonds pile up.
They Stare At Rocks. Then Charge Astronomical Amounts of Money.
Here’s the breakdown: A diamond miner sells rough stones to a cutter. The cutter polishes it. A lab grower makes lab-grown diamonds in a factory (cheaper, faster, chemically identical). A jeweller cuts both into jewellery. And at every step, people panic: “Is this real?” “Is this good quality?” “Is it overpriced?”
IGI walks in. Looks at it. Grades it on the 4Cs (Cut, Color, Clarity, Carat). Adds extra detail like fluorescence and symmetry. Stamps a certificate. Charges ₹800–₹1,200 depending on stone type and weight. Repeat 3.2 million times per quarter.
Revenue split (CY25): Lab-grown diamonds ~59%, Natural diamonds ~19%, Studded jewellery ~20%, Education + ads ~2%. The mix is critical — lab-grown stones have lower ASP (average selling price) but higher volume. Natural diamonds have premium pricing. Studded jewellery is high-volume, low-realization (because you’re grading 100 diamonds in one piece, using “split grades”).
CY25 Full Year: The Numbers That Made ICICI Prudential Sit Up
Result type: Full Year Results (CY25) | Full Year EPS: ₹12.30 | Q4 EPS: ₹3.11 | Annualised EPS (Q4×4): ₹12.44 | CY25 PAT Growth: +24%
Source table
| Metric (₹ Cr) | CY25 (Dec 2025) Full Year |
CY24 (Dec 2024) Full Year |
Q4 CY25 Dec 2025 |
Q4 CY24 Dec 2024 |
YoY % |
|---|---|---|---|---|---|
| Revenue | 1,229 | 1,053 | 320 | 265 | +16.7% |
| EBITDA | 737 | 600 | 191 | 152 | +22.8% |
| EBITDA Margin % | 60% | 57% | 60% | 57% | +300 bps |
| PAT | 532 | 427 | 135 | 114 | +24.4% |
| EPS (₹) | 12.30 | 9.89 | 3.11 | 2.63 | +24.3% |
Is ₹321 The Price of Brilliance or Delusion?
Method 1: P/E Based
CY25 full-year EPS = ₹12.30. Sector median P/E (business services) = 20.2x. IGI trades at 26.1x due to ROCE superiority (53.6% vs sector ~20%) and margin profile (60% EBITDA). Fair P/E band considering growth trajectory: 20x–28x.
Range: ₹246 – ₹344
Method 2: EV/EBITDA Based
CY25 EBITDA = ₹737 Cr. Current EV = ₹13,531 Cr → EV/EBITDA = 18.4x. Quality business service / tech-enabled comps trade at 15x–22x. Near-zero net debt, but ₹143 Cr borrowings.
EV range (15x–22x): ₹11,055 Cr – ₹16,214 Cr → Per share (43.2 cr shares):
Range: ₹256 – ₹375
Method 3: DCF Based
Base FCF: ₹502 Cr (CY25 operating CF). Growth: 18% for 3 years (lab-grown tailwind), then 10% for 2 years, normalizing to 7%. Terminal growth: 4%. WACC: 10%.
→ Terminal Value (4% growth / 6% cap rate): ~₹14,130 Cr
→ Total EV: ~₹17,980 Cr (net cash ~₹720 Cr)
Range: ₹270 – ₹360
The Gemstone Gossip Aisle Gets Interesting
🔴 The Big One: Acquired AGL (American Lab-Grown Powerhouse) for $13.2M
On January 31, 2026, IGI board approved acquisition of AGL Holdco (100% stake) for USD 13.2 million. Effective February 10, 2026. This is IGI’s play to dominate lab-grown certification in the USA — the world’s largest jewelry market. American lab growers have been relying on local (and sometimes sketchy) certification providers. IGI is bringing third-party credibility to the US LGD market. Strategic bet: correct.
✅ Dividend Declared (Feb 11, 2026)
- • Interim dividend: ₹2.50 per share (432.2 cr shares)
- • Record date: Feb 17, 2026
- • Payment mode: announced post-board approval
- • Message: “we make too much money, here, take some”
⚠️ Company Name Change (Feb 11, 2026)
- • Board approved change in company name
- • Details not yet disclosed (watch for filing)
- • Likely related to AGL acquisition branding
- • Could signal consolidation of IGI USA operations
✅ Strategic Hires & US Expansion
- • Siddharth Sule appointed IGI Head – Global Marketing (Dec 2025)
- • US building “strong sales organization” over 2–3 months
- • US cost rationalization already underway (non-India opex focus)
- • Natural diamonds marked as “critical priority” post-2026
⚠️ India Retail Retailer Self-Certifying LGD?
- • One large Indian retailer issuing own LGD certificates (test phase)
- • Management downplayed, said it’s “likely testing”
- • IGI “already in touch” with this retailer
- • Watch-item: short-term outcome “in very short future”
Is the Fort Financially Sound?
Source table
| Item (₹ Cr) | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 (Latest) |
|---|---|---|---|---|
| Total Assets | 409 | 603 | 1,504 | 1,755 |
| Net Worth (Eq + Reserves) | 339 | 509 | 1,062 | 1,409 |
| Borrowings | 27 | 31 | 145 | 143 |
| Other Liabilities | 43 | 64 | 296 | 203 |
| Total Liabilities | 409 | 603 | 1,504 | 1,755 |
Borrowings: ₹143 Cr (down from ₹145 Cr). Interest coverage: 75.8x. Their interest expense is probably less than their coffee budget. Debt-to-equity: 0.10x. Basically, they don’t need to borrow money.
Other Assets shot up to ₹1,286 Cr (from ₹1,084 Cr). Includes ~₹860 Cr in bank balances and FDs as of Dec 2025. Net cash position = ₹717 Cr. Enough to fund AGL acquisition 10x over.
Assets grew 3x in 3 years (Dec 2022 to Dec 2025). Net worth grew 4.1x. This is post-IPO expansion, Surat facility commissioning, and geographic scaling. Balance sheet is fortress-like.
Who’s Actually Printing Money?
Source table
| Cash Flow (₹ Cr) | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating CF | +194 | +303 | +393 | +502 |
| Investing CF | -43 | -85 | -1,634 | -307 |
| Financing CF | -154 | -162 | +1,188 | -248 |
| Net Cash Flow | -2 | 55 | -52 | -53 |
These Numbers Are Embarrassingly Good
Annual Trends — CY22 to CY25 (Four Years of Compounding)
Source table
| Metric (₹ Cr) | CY22 | CY23 | CY24 | CY25 |
|---|---|---|---|---|
| Revenue | 491 | 639 | 1,053 | 1,229 |
| EBITDA | 335 | 450 | 600 | 737 |
| EBITDA Margin % | 68% | 71% | 57% | 60% |
| PAT | 242 | 325 | 427 | 532 |
| EPS (₹) | — | — | 9.89 | 12.30 |
CY22–CY24 saw margin compression (from 68% to 57%) as the company expanded labs and infrastructure for IPO. CY25 sees margin recovery as these assets scale. This is a sign of operating leverage kicking in. Revenue growth at 35% CAGR is hypergrowth for a services business. PAT at 30% CAGR. Textbook execution.
IGI vs The Certification Nobodies
Source table
| Company | Sales (₹ Cr) | PAT (₹ Cr) | P/E | ROCE % | OPM % |
|---|---|---|---|---|---|
| IGI (India) | 1,229 | 532 | 26.1x | 53.6% | 60% |
| NESCO Ltd | 872 | 408 | 18.3x | 21.1% | 55% |
| CMS Info Systems | 2,473 | 330 | 14.9x | 23.7% | 24% |
| Nirlon Ltd | 656 | 329 | 13.4x | 30.2% | 78% |
Sector median P/E: 20.2x. IGI at 26.1x is a premium of ~29%, justified by 53.6% ROCE vs sector average 23.7%. Nobody in this peer set makes money like IGI. WeWork’s ROCE calculation is broken (shows 137%, which is impossible). Nirlon has 78% OPM (cash management company, not comparable). IGI stands alone.
Who Owns The Bling Referee?
- Promoters (BCP Asia II Topco)76.55%
- Public8.39%
- FIIs9.61%
- DIIs (incl. ICICI Prudential funds)5.44%
Pledge: 0.00%. Public shareholders: 183,950. IPO just 2.5 months old (December 24). Stock already tripled from ₹100 IPO price to ₹321 CMP. Retail participation high.
Promoter: BCP Asia II Topco (Singapore)
BC Partners, a leading global PE firm, bought IGI globally in 2022 for ~₹1,500 Cr. Listed IGI India in Dec 2024 at ₹4,225 Cr valuation. IPO was a partial exit. BC Partners retains 76.6%. Post-IPO, they’ve been quiet but strategic — funding AGL acquisition, dividend declaration, margin expansion. Classic PE playbook: own high ROCE assets, grow them, then harvest.
Govt of Singapore Lurking (1.32%)
Singapore’s government holds 1.32% of the company. Likely via Temasek or a sovereign fund. Not activist. Just a long-term holder betting on global diamond certification growth. Which is… correct.
The Boring But Critical Stuff (That Matters)
✅ The Clean Sheet
- ✓ Clean audit history — no material qualifications
- ✓ Board active — approved AGL acquisition (Jan 31, 2026)
- ✓ Dividend declared (₹2.50) — confidence signal
- ✓ Company name change approved — strategic refinement
- ✓ Quarterly concalls maintained (Feb, Nov, Aug, Apr)
- ✓ Interest coverage: 75.8x — debt irrelevant
- ✓ Pledge: 0.00% — zero promoter financial stress
⚠️ Watch List
- ⚠ PE ownership concentration (76.6%) — minority shareholder risk
- ⚠ IPO only 2.5 months old — minimal track record as public company
- ⚠ Reporting calendar change (Jan–Dec → Apr–Mar) — still transitioning
- ⚠ US expansion aggressive (AGL, sales team) — execution risk in new market
- ⚠ Lab-grown retail certification risk (if retailer self-certifies) — watch
- ⚠ International tariff exposure (US focus, India manufacturing)
Diamonds, Disruption, and Dentists Panic
The global diamond and gemstone certification market is ~$5–6 billion annually. India is 15–20% of that. Lab-grown diamonds are the growth story — they’re chemically identical to natural, cheaper by 30–40%, and grown in factories instead of mined from conflict zones. Perfect for millennial engagement rings (ethical, cheaper, no blood diamonds).
🔬 Lab-Grown Diamonds: The Canary & The Coal Mine
LGD volume growing 20%+ annually globally. India’s LGD manufacturers (Surat cluster) supply 70% of global LGD rough. IGI certified 12.81 million stones in CY25 — roughly 65% LGD (loose stones & jewellery combined). As LGD retail penetration climbs (already 1,000+ retail showrooms in India), certification becomes non-negotiable. Retailers need assurance. Consumers panic without certificates. IGI profits.
💎 Natural Diamonds: Why Suddenly Growing?
Management flagged ND growth +20% YoY. The reason: “people are also certifying more of natural to ensure that it is not lab grown.” Translation: LGD’s existence created a trust crisis in natural diamonds. Buyers now demand ND certificates to verify authenticity. This is accidental demand creation. A competitor’s rise creating incremental demand for your core service. Genius.
💰 The ASP & Mix Magic: Where Margins Hide
ND loose stones have highest ASP (average selling price per certificate). Jewellery has lowest. IGI’s mix is shifting toward loose stones (ND +53%, LGD +47% in Q4 India). This 19% ASP improvement in India alone is huge. Management is not increasing prices — they’re selling into higher-value segments. That’s the execution edge nobody talks about.
⚠️ The Threat: One Large Retailer Self-Certifying?
One Indian retailer (unnamed) started issuing own LGD certificates. Management downplayed it (“testing phase”), but this is the existential threat. If large retailers build their own in-house certification, IGI’s relevance collapses. Why pay ₹1,000 per certificate when you can build a lab in 3 years and certify in-house? Management said they’re “in touch” and outcome will be clear “in very short future.” This is a 2-year watch item, not a 6-month panic.
Competitive Dynamics: Global certification market is fragmented. IGI holds 33% global market share, 50% India market share. GIA (Gemological Institute of America) is the other major player — older, established, but slower. Third-tier players exist (Agra-based labs, private certifiers) but lack credibility. IGI’s moat is brand + scale + 31 labs across 10 countries. Replicating that takes $50 million+ and 5+ years. Durable.
Macro Tailwinds: India’s wedding season (Dec–Jan) drives jewellery demand. Global LGD adoption accelerating (US penetration still low, ~5–10%). Middle-class expansion in Asia = more diamond buyers. Engagement ring culture spreading in India (was taboo, now trendy). E-commerce jewelry (which needs certification more) growing 40%+ annually.
Macro Headwinds: US tariffs on imports (China → US) and potential India tariffs (if bilateral trade friction). Lab-grown wholesale prices stable 18 months, but manufacturers’ margins are 8–10% (could compress). AI-driven grading could eventually automate routine certifications (low-probability, 5–10 year horizon). De Beers’ marketing push on natural diamonds might slow LGD adoption (unlikely, given economics).
The Final Cut On the Diamond Referee
IGI is a certification monopoly masquerading as a services business. 60% EBITDA margins. 53.6% ROCE. PAT margins north of 43%. ₹502 crore operating cash flow. Zero dividend culture (until Feb 2026). These are the metrics of a mature pricing-power machine. The IPO at ₹4,225 crore in December 2024 has already compounded to ₹13,852 crore (227% gain). That’s not value discovery — that’s a market recognition event.
CY25 Execution: Revenue +17%. PAT +24%. EBITDA margin expansion of 300 bps from CY24 to CY25. Volume grew 21% (12.81m reports). Mix shifted toward higher-ASP loose stones. India market share cemented at 50%. This is not hypergrowth; it’s compounding execution in a secular growth market.
The AGL Acquisition: USD 13.2 million for an American lab-grown certification provider is a small bet with huge optionality. US lab-grown market is nascent (5–10% penetration) vs India (already 40%+). If IGI can replicate India’s 50% market share in the US within 5 years, this acquisition will be worth 10x the price. Management’s framing: correct.
Historical Context: IPO’d at ₹100 in Dec 2024. CMP is ₹321. That’s a 221% return in 2.5 months. Market is pricing in: (1) lab-grown diamond adoption secular tailwind, (2) IGI’s pricing power, (3) margin expansion as it scales. The P/E of 26.1x vs sector median 20.2x is justified. The premium is not delusion — it’s recognition of a different business class.
Valuation Sanity Check: At ₹321 CMP and ₹12.30 EPS, P/E is 26.1x. If lab-grown grows 18–20% annually for the next 3 years and IGI captures 50%+ of incremental volume, EPS could hit ₹18–22 by CY28. That would make current P/E look cheap at 14–17x. The math is not impossible. It’s actually reasonable.
✓ Strengths
- 50% India market share — lab-grown certification dominance
- 33% global market share in certifications — brand moat
- 60% EBITDA margin — operating leverage unmatched
- ₹502 Cr annual operating CF — cash generation is absolute
- 31 labs across 10 countries — geographic diversification
- ROCE 53.6% — capital efficiency superlative
✗ Weaknesses
- PE ownership (76.6%) — minority shareholder dilution risk
- Young IPO (2.5 months) — track record as public company minimal
- ASP compression risk — if LGD prices fall further
- Scale-up costs (US, AGL integration) — near-term margin headwinds
- Tariff exposure — US manufacturing tariffs could squeeze margins
→ Opportunities
- US lab-grown market: 5–10% penetration vs India 40%+ — runway
- E-commerce jewelry growth 40%+ annually — need certification
- Natural diamond coexistence — ND demand growing +20% (authentication)
- Geographic expansion: China, Southeast Asia — nascent markets
- AI-assisted grading tools — could enhance (not replace) margins
⚡ Threats
- Retailer self-certification (India) — if scaled, existential
- Lab-grown price crash — wholesale prices could compress 20%+
- GIA expansion into lab-grown — competitive pressure on volume
- US tariffs on diamond imports — margin squeeze
- Regulation: if India mandates in-country certification only
IGI is not a growth story in the traditional sense. It’s a market-share consolidation story in an industry that desperately needs one credible referee.
For 50 years, global diamond certification was fragmented. GIA, IGI, and dozens of marginal players coexisted. Lab-grown’s arrival forced buyers to demand credibility. IGI walked in with 31 labs, 50-year track record, and global scale. Now they’re the de facto monopoly. That moat is durable. That pricing power is real. That margin profile is legitimate.
At ₹321 CMP and a fair value range of ₹246–₹375, the stock is fairly valued, not cheap. Post-IPO momentum is normalizing. The risk is not “valuation crash” — it’s “execution miss” (AGL integration fails, retailer self-cert goes mainstream, tariff shock). For long-term compounders, IGI is a defensible position in a secular growth market. For short-term traders, the easy 200% gain is already priced in. What happens next is harder.